Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash & Current Investments (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Cash & Current Investments for 14 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 7.95% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, down 7.95% year-over-year, with the annual reading at $7.9 million for FY2025, 7.95% down from the prior year.
  • Cash & Current Investments hit $7.9 million in Q4 2025 for STRATA Skin Sciences, up from $7.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $17.5 million in Q1 2021 to a low of $4.2 million in Q1 2023.
  • Historically, Cash & Current Investments has averaged $9.4 million across 5 years, with a median of $8.4 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: tumbled 61.68% in 2023 and later soared 56.98% in 2024.
  • Year by year, Cash & Current Investments stood at $12.6 million in 2021, then crashed by 46.01% to $6.8 million in 2022, then increased by 19.47% to $8.1 million in 2023, then grew by 5.88% to $8.6 million in 2024, then fell by 7.95% to $7.9 million in 2025.
  • Business Quant data shows Cash & Current Investments for SSKN at $7.9 million in Q4 2025, $7.1 million in Q3 2025, and $6.0 million in Q2 2025.